Botulinum toxin-A injections into neurogenic overactive bladder-To include or exclude the trigone? A prospective, randomized, controlled trial

Journal of Urology

Volumn 184, Issue 6, 2010, Pages 2423-2428

  Abdel Meguid, Taha A ^a,b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b MINIA UNIVERSITY   (Egypt)

Author keywords

Botulinum toxin type A; Spinal cord injuries; Urinary bladder neurogenic; Urinary incontinence; Urodynamics

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOMETRY; DRUG EFFICACY; FEMALE; HUMAN; MALE; NEUROGENIC BLADDER; OVERACTIVE BLADDER; PARAMETER; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SPINAL CORD INJURY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VESICOURETERAL REFLUX;

ADMINISTRATION, INTRAVESICAL; ADULT; BOTULINUM TOXINS, TYPE A; FEMALE; HUMANS; MALE; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; URINARY BLADDER, NEUROGENIC; URINARY BLADDER, OVERACTIVE; YOUNG ADULT;

EID: 78349309984     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.08.028     Document Type: Article

References (21)

1. C.P. Smith, G.T. Somogyi, and M.B. Chancellor Emerging role of botulinum toxin in the treatment of neurogenic and non-neurogenic voiding dysfunction Curr Urol Rep 3 2002 382
2. G. Karsenty, P. Denys, and G. Amarenco Botulinum toxin A (Botox®) intradetrusor injections in adults with neurogenic detrusor overactivity/ neurogenic overactive bladder: a systematic literature review Eur Urol 53 2008 275
3. D.E. Rapp, A. Lucioni, and G.T. Bales Botulinum toxin injection: a review of injection principles and protocols Int Braz J Urol 33 2007 132
4. A.K. Patel, J.M. Patterson, and R. Christopher Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: a critical analysis of results Eur Urol 50 2006 684
5. A. Apostolidis, P. Dasgupta, and P. Denys Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report Eur Urol 55 2009 100
6. H.C. Kuo Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity J Urol 178 2007 1359
7. D.H. Zermann, M. Ishigooka, and R.A. Schmidt Trigonum and bladder base injection of botulinum toxin A (BTX) in patients with severe urgency-frequency syndrome refractory to conservative medical treatment and electrical stimulation Neurourol Urodyn 20 2001 412 abstract 27
8. Y.C. Chuang, N. Yoshimura, and C.C. Huang Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat J Urol 180 2008 742
9. C. Chapple, and A. Patel Botulinum toxinnew mechanisms, new therapeutic directions? Eur Urol 49 2006 606
10. A. Apostolidis, P. Dasgupta, and C.J. Fowler Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity Eur Urol 49 2006 644
11. L.A. Klein Urge incontinence can be a disease of bladder sensors J Urol 139 1988 1010
12. W. Schafer, P. Abrams, and L. Liao Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies Neurourol Urodyn 21 2002 261
13. M. Stohrer, M. Goepel, and A. Kondo The standardization of terminology in neurogenic lower urinary tract dysfunction: with suggestions for diagnostic procedures International Continence Society Standardization Committee Neurourol Urodyn 18 1999 139
14. P. Abrams, L. Cardozo, and M. Fall The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society Neurourol Urodyn 21 2002 167
15. B. Schurch, M. Stohrer, and G. Kramer Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results J Urol 164 2000 692
16. G. Karsenty, E. Elzayat, and T. Delapparent Botulinum toxin type A injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux J Urol 177 2007 1011
17. B. Schurch, M. de Seze, and P. Denys Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study J Urol 174 2005 196
18. A. Giannantoni, E. Mearini, and M. Del Zinaro Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results Eur Urol 55 2009 705
19. G. Karsenty, A. Reitz, and G. Lindemann Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity Urology 68 2006 1193
20. A. Reitz, P. Denys, and C. Fermanian Do repeat intradetrusor botulinum toxin type A injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity Eur Urol 52 2007 1729
21. A. Apostolidis, T.S. Jaques, and A. Freeman Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity Eur Urol 53 2008 1245